Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 30.25
+0.25 (0.83%)
Aug 19, 2026, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 16.19 billion as of August 19, 2026. Its market cap has decreased by -9.56% in one year.
Market Cap
16.19B
Enterprise Value
17.30B
Revenue
6.37B
Ranking
n/a
PE Ratio
20.11
Stock Price
30.25
ChartMarket Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 16.19B, an increase of 2,674.83%. That is a compound annual growth rate of 17.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 16.19B | -0.35% |
| Dec 31, 2025 | 16.25B | 12.06% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 25.04B |
| TTY Biopharm Company | 19.00B |
| ScinoPharm Taiwan | 14.87B |
| YungShin Global Holding | 14.49B |
| Grape King Bio | 13.21B |
| Handa Pharmaceuticals | 12.76B |
| Foresee Pharmaceuticals | 12.48B |
| Standard Chemical & Pharmaceutical | 10.99B |